OAM
VYNT

Oxford Asset Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Oxford Asset Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,716
Closed -$141K – 1487
2019
Q4 		$141K Buy
+4,716
New +$113K ﹤0.01% 1593

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Oxford Asset Management's VYNT Position: Q1 2020 in Review

Oxford Asset Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2020, closing a stake of 4,716 shares — an estimated $141K sold.

Oxford Asset Management first reported a position in VYNT in Q4 2019 and held it in 1 quarter. The position peaked at $141K in Q4 2019. 13 funds tracked by Wall St. Rank hold VYNT as of Q1 2020.

  • Oxford Asset Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 4,716 Vyant Bio, Inc. Common Stock shares in Q1 2020, an estimated $141K.
  • Oxford Asset Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Oxford Asset Management's Vyant Bio, Inc. Common Stock position peaked at $141K in Q4 2019.
  • 13 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.